{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:59:59Z","timestamp":1788872399887,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical Co., Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jjcc.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T17:20:23Z","timestamp":1350062423000},"page":"462-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Short-term effects of low-dose tolvaptan on hemodynamic parameters in patients with chronic heart failure"],"prefix":"10.1016","volume":"60","author":[{"given":"Kiyotaka","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiyo","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Nobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2012.09.002_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jjcc.2010.08.005","article-title":"Improvement of autonomic nervous activity by Waon therapy in patients with chronic heart failure","volume":"57","author":"Kuwahata","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jjcc.2012.01.008","article-title":"Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure","volume":"59","author":"Nishi","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0015","first-page":"e391","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"issue":"Suppl. A","key":"10.1016\/j.jjcc.2012.09.002_bib0020","doi-asserted-by":"crossref","first-page":"A36","DOI":"10.1253\/circj.CJ-08-1106","article-title":"Management of severe heart failure","volume":"73","author":"Hiramitsu","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jjcc.2011.12.007","article-title":"Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF)","volume":"59","author":"Miyata","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/eurheartj\/ehi176","article-title":"Diuretic usage in heart failure: a continuing conundrum in 2005","volume":"26","author":"Gupta","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0035","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.74.6.1303","article-title":"Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure","volume":"74","author":"Stevenson","year":"1986","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.jjcc.2012.09.002_bib0040","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s10557-011-6304-x","article-title":"Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study)","volume":"25","author":"Matsuzaki","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0045","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","article-title":"OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats","volume":"287","author":"Yamamura","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0050","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0055","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","article-title":"Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure","volume":"290","author":"Costello-Boerrigter","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl. 1","key":"10.1016\/j.jjcc.2012.09.002_bib0060","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1007\/s10557-011-6349-x","article-title":"Phase III clinical pharmacology study of tolvaptan","volume":"25","author":"Inomata","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0065","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0735-1097(01)01383-3","article-title":"Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction","volume":"38","author":"Stanek","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0070","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.jjcc.2012.09.002_bib0075","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/s10557-011-6303-y","article-title":"Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"25","author":"Matsuzaki","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0049-3848(87)90252-0","article-title":"Mechanism of vasopressin-induced platelet aggregation","volume":"45","author":"Filep","year":"1987","journal-title":"Thromb Res"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0085","first-page":"351","article-title":"Thirst and vasopressin function in normal and disordered states of water balance","volume":"101","author":"Robertson","year":"1983","journal-title":"J Lab Clin Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jjcc.2012.09.002_bib0090","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s10557-011-6350-4","article-title":"Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure","volume":"25","author":"Onogawa","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0095","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2011.08.005","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction","volume":"17","author":"Udelson","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0100","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jacc.2008.08.013","article-title":"Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial","volume":"52","author":"Udelson","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0105","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1253\/circj.CJ-10-0869","article-title":"Heart failure and the lung","volume":"74","author":"Kee","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0110","first-page":"H415","article-title":"Vasopressin-induced pulmonary vasodilation in rats","volume":"257","author":"Walker","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0115","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1210\/endo.138.10.5432","article-title":"The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways","volume":"138","author":"Thibonnier","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.jjcc.2012.09.002_bib0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/qjmed\/hcl009","article-title":"The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension","volume":"99","author":"Smith","year":"2006","journal-title":"QJM"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508712002043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508712002043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:50:51Z","timestamp":1760273451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508712002043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0914508712002043"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2012.09.002","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term effects of low-dose tolvaptan on hemodynamic parameters in patients with chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2012.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}